Clinical Trial Update: Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38 [NA]

View source ↗

Summary

Clinical trial entry describes induction of migraine attacks with aura using PACAP-38; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine with Aura

Drugs mentioned

• PACAP-38 (pituitary adenylate cyclase-activating polypeptide-38)

Snippet

Sponsor: Danish Headache Center | Conditions: Migraine With Aura, Migraine Aura | NA | Status: NOT_YET_RECRUITING